Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selective Nerve Root Injections for Lumbar Disc Herniation
NCT01073995Phase 3Completed
- Sponsor
- Horizon Health Network
- Start
- Mar 2010
- Primary completion
- Nov 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of triamcinolone and bupivacaine in radiculopathy and lumbar disc herniation (LDH) (2 arms), sponsored by Horizon Health Network. Primary endpoint: Surgical Avoidance at 5 years. Started Mar 2010; status: completed.
02
Drugs
triamcinolonebupivacaine
03
Conditions
radiculopathylumbar disc herniation (LDH)
Beyond the preview
Go deeper on NCT01073995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01073995.